Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,930 | 118,621 | 51,304 | N/A | N/A |
| Marketable Securities | 62,362 | N/A | N/A | N/A | N/A |
| TOTAL | $107,776 | $120,036 | $51,955 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 12 | 13 | 7 | N/A | N/A |
| Investments And Advances | 6,648 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 23 | 23 | 950 | 0 | 0 |
| TOTAL | $6,683 | $36 | $957 | $N/A | $N/A |
| Total Assets | $114,459 | $120,072 | $52,912 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 239 | 207 | 652 | 0 | 0 |
| Accrued Expenses | 1,548 | 520 | 581 | N/A | N/A |
| TOTAL | $1,787 | $727 | $1,233 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,787 | $727 | $1,233 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,634 | 16,634 | 16,630 | N/A | 15,941 |
| Common Shares | 2 | 2 | N/A | N/A | N/A |
| Retained earnings | -30,962 | -23,840 | -17,097 | N/A | N/A |
| Other shareholders' equity | -28 | 0 | 68,049 | 0 | 0 |
| TOTAL | $112,672 | $119,345 | $51,679 | $N/A | $N/A |
| Total Liabilities And Equity | $114,459 | $120,072 | $52,912 | $0 | $0 |